Last reviewed · How we verify

NCT03566537

Alterations in Quality of Life After Thyroidectomy for Benign Thyroid Disease

Completed Last updated 27 April 2021
What this trial tests

trial testing Thyroidectomy in Benign Thyroid Nodule in 73 participants. Completed in 11 January 2021.

Timeline
11 June 2018
Primary endpoint
11 June 2020
11 January 2021

Quick facts

Lead sponsorAristotle University Of Thessaloniki
StatusCompleted
Study typeOBSERVATIONAL
Enrollment73
Start date11 June 2018
Primary completion11 June 2020
Estimated completion11 January 2021
Sites1 location across Greece

Drugs / interventions tested

Conditions studied

Sponsor

Aristotle University Of Thessaloniki

Who can join

18 and older, any sex, with Benign Thyroid Nodule or Quality of Life. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To detect any changes in Quality of Life in patients with benign thyroid diseases who undergo thyroidectomy compared to patients with benign thyroid diseases and conservative treatment and healthy subjects.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Thyroidectomy

Trials testing the same drug.

Other recruiting trials for Benign Thyroid Nodule

Currently open trials in the same condition.

Other Aristotle University Of Thessaloniki trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03566537.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing